explore -WSS

explore

author：focus 2025-09-02 11:39:31 - browse：172

Chemotherapy infusion — The White House outlined its efforts to end shortages of three key generic chemotherapies. But experts want more more details. Gerry Broome/AP

WASHINGTON — The White House says it’s working to end shortages of three key generic chemotherapies. But experts said the administration would have to provide more details to fully mitigate the health care system’s concerns.

Carboplatin, cisplatin, and methotrexate are three of 15 cancer drugs in shortage in the United States. They have been staples of cancer treatment for decades, according to a White House blog post, but their supply in the United States has been nearly halved in the past year. The shortages have forced doctors to ration the drugs and alter treatment plans, leaving cancer patients to wonder whether their survival odds are hurt.

In its blog post, the White House noted that it’s now allowing Chinese imports of cisplatin. The Food and Drug Administration is also working with generic drug companies to boost production of all three drugs, but it didn’t say which companies.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： FDA warns J&J's Abiomed: We will regulate your software

hotspot

WSS

Why health workers in Gaza are injured or die at high rates

STAT Summit: How a Chicago ER doctor tackles gun violence

Senate committee scrutinizes Medicare Advantage brokers

Physicians and social media: If you see something, say something?

UnitedHealth’s board chair also owns a personal investment firm

Readout Newsletter: Bluebird, CVS, Contineum

Wikipedia

explore

Wikipedia

Medicare details structure of new drug price negotiation program

U.K. not yet recommending Vertex's CRISPR therapy for sickle cell

Trump demands the U.S. pay no more for drugs than other countries … again

Intermittent fasting comes with a heart risk? Not so fast

Medicare proposal to cover medical devices draws a mixed reaction

Physicians and social media: If you see something, say something?

Apple is now the first public company to be valued at $3 trillion

STAT Summit: Michael J. Fox on progress in Parkinson's research

New air purifier tech could be key to improving indoor air quality

Asbestos, a deadly carcinogen, banned by EPA

hotspot

Stop the failed accountable care organization experiment

Virtual Event: March of the Biosimilars

SCOTUS questions limit to govt efforts to fight misinformation

UnitedHealth’s board chair also owns a personal investment firm

Methadone treatment changes are coming. Do they go far enough?

Stop the failed accountable care organization experiment

focus

hotspot

explore

hotspot